Finally, the overall mechanism of this study is shown in Figure 6J, which demonstrates that FOXM1-ZIC2-UBE2C-AKT/mTOR signaling promotes the malignant phenotype of ccRCC. This evidence concerns the gene UBE2C and nonpapillary renal cell carcinoma.